Mint Explainer: Inside Natco’s high-stakes patent challenge strategy

Natco Pharma has secured yet another favourable ruling against a drug innovator, allowing it to sell a generic version of a rare-disease treatment at a fraction of the original price. Mint dissects its playbook.

Industry